THRAP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.97890045963811E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.70239999950506E-07 |
Normal-vs-Stage2 |
5.40559999984147E-07 |
Normal-vs-Stage3 |
3.19779980273438E-10 |
Normal-vs-Stage4 |
1.18799999837549E-08 |
Stage1-vs-Stage2 |
5.424000E-02 |
Stage1-vs-Stage3 |
3.677800E-03 |
Stage1-vs-Stage4 |
2.050200E-02 |
Stage2-vs-Stage3 |
8.369600E-01 |
Stage2-vs-Stage4 |
9.759400E-01 |
Stage3-vs-Stage4 |
8.403200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.75259967333852E-10 |
Normal-vs-AfricanAmerican |
7.62720000491157E-08 |
Normal-vs-Asian |
4.686200E-01 |
Caucasian-vs-AfricanAmerican |
1.280650E-01 |
Caucasian-vs-Asian |
1.485380E-01 |
AfricanAmerican-vs-Asian |
5.802000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.80961970040062E-12 |
Normal-vs-Female |
1.76512999999767E-05 |
Male-vs-Female |
1.115820E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.202730E-03 |
Normal-vs-Age(41-60Yrs) |
1.83759999994315E-07 |
Normal-vs-Age(61-80Yrs) |
2.01670014021715E-10 |
Normal-vs-Age(81-100Yrs) |
2.73910000003763E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.251400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.644000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.663800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.210800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.126500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.312990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.050200E-01 |
Normal-vs-Grade 2 |
2.32879999999547E-05 |
Normal-vs-Grade 3 |
2.04547490056939E-12 |
Normal-vs-Grade 4 |
1.11230002985963E-09 |
Grade 1-vs-Grade 2 |
2.610400E-02 |
Grade 1-vs-Grade 3 |
9.69480000000411E-05 |
Grade 1-vs-Grade 4 |
2.016000E-04 |
Grade 2-vs-Grade 3 |
4.2388999999976E-05 |
Grade 2-vs-Grade 4 |
8.790400E-04 |
Grade 3-vs-Grade 4 |
6.215800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.200600E-04 |
Normal-vs-ccB subtype |
1.37399980282282E-10 |
ccA subtype-vs-ccB subtype |
4.34930000003941E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.51459999676274E-09 |
Normal-vs-N1 |
1.516610E-03 |
N0-vs-N1 |
5.937200E-01 |
|
|